. 1990;17(4):330-6.

Aminoglycoside therapy: current and prospective uses

Affiliations

Free PMC article

J E Leggett. Tex Heart Inst J. 1990.

Free PMC article

. 1990;17(4):330-6.

¹ The Department of Medical Education, Providence Medical Center, Portland, Oregon 97213-2967, USA.

No abstract available

Similar articles

A practical approach enabling staff pharmacists to prospectively review and dose aminoglycoside therapy.
Possidente CJ, Lynch T. Possidente CJ, et al. Hosp Pharm. 1988 Nov;23(11):976-8, 981-3. Hosp Pharm. 1988. PMID: 10290757
Aminoglycoside therapy in infectious diseases.
Poulikakos P, Falagas ME. Poulikakos P, et al. Expert Opin Pharmacother. 2013 Aug;14(12):1585-97. doi: 10.1517/14656566.2013.806486. Epub 2013 Jun 8. Expert Opin Pharmacother. 2013. PMID: 23746121 Review.
Influence of multiple courses of therapy on aminoglycoside clearance in adult patients with cystic fibrosis.
Alghanem S, Paterson I, Touw DJ, Thomson AH. Alghanem S, et al. J Antimicrob Chemother. 2013 Jun;68(6):1338-47. doi: 10.1093/jac/dkt035. Epub 2013 Feb 23. J Antimicrob Chemother. 2013. PMID: 23435691
Does aminoglycoside therapy cause significant acute kidney injury in febrile neutropenia?
Hajkowicz KM, Post JJ. Hajkowicz KM, et al. Int J Antimicrob Agents. 2011 Jan;37(1):78-81. doi: 10.1016/j.ijantimicag.2010.08.017. Int J Antimicrob Agents. 2011. PMID: 21163406
Antibiotic use in neonatal sepsis.
Yurdakök M. Yurdakök M. Turk J Pediatr. 1998 Jan-Mar;40(1):17-33. Turk J Pediatr. 1998. PMID: 9722468 Review.

Correlation of the pharmacokinetic parameters of amikacin and ceftazidime.
Panomvana D, Kiatjaroensin SA, Phiboonbanakit D. Panomvana D, et al. Clin Pharmacokinet. 2007;46(10):859-66. doi: 10.2165/00003088-200746100-00004. Clin Pharmacokinet. 2007. PMID: 17854235 Clinical Trial.